President Trump makes extraordinary claims about the success of the
Right to Try law, which was designed to give terminally ill people access to experimental medical treatments before they’ve been approved by the Food and Drug Administration. “I tell you, it’s a miracle — so many people have been saved,” he said at a
rally in Lake Charles, La., last month, describing how desperately ill people were, thanks to him, able to access the work of the “best doctors and labs, technicians in the world.” When he signed the law in May 2018, he used even more sweeping language: “We will be saving … thousands and thousands, hundreds of thousands” of lives. The Trump 2020 campaign has used the law to
promote the idea that the GOP is “the party of health care.”
Unfortunately, Right to Try appears to be helping very few people. The “incredible” transformation that Trump described in Louisiana is a fantasy: Right to Try mainly succeeds at giving its political backers a cheap public relations victory, even as they exploit the hopes of dying Americans.
...
It’s true that the “expanded access” pathway isn’t perfect. Ethical-review boards sometimes raise unnecessary objections to allowing people to access experimental drugs; the standards they apply could be made more consistent, and extending legal protections to drugmakers that allow such access makes sense. But Right to Try has done little, if anything, to increase access to investigational drugs, and it’s a cruel falsehood to tell terminally ill people that the law has led to hundreds or thousands of “miraculous” recoveries.